全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Esophageal Electrical Cardioversion of Atrial Fibrillation: When Esophagus Gives a Help to Cardiologists

DOI: 10.4061/2011/983937

Full-Text   Cite this paper   Add to My Lib

Abstract:

Atrial fibrillation is a common clinical disease especially in the elderly and in patients with organic heart disease. Electrical cardioversion is the first choice therapeutic approach for patients in which sinus rhythm could improve the quality of life and where the maintenance of sinus rhythm is considered likely. There are different techniques to perform an electrical cardioversion, each with specific indications, advantages, and limitations. The method most frequently used to restore sinus rhythm is external direct current cardioversion; however, this technique has some disadvantages, since it requires a high energy and usually general anesthesia. Esophageal cardioversion is an alternative method to obtain restoration of sinus rhythm, warranting acute and long-term results absolutely comparable with those obtained by the conventional transthoracic technique, especially in obese and COPD patients with high thoracic impedance for whom the standard technique may be less effective. 1. Introduction Atrial fibrillation is a common clinical disease especially in the elderly (3–5% of the population over 60 years), and in patients with organic heart disease (70–80%) [1]. Electrical cardioversion (ECV) is the first-choice therapeutic approach for patients in which sinus rhythm could improve the quality of life and where the maintenance of sinus rhythm is considered likely. This technique compared with pharmacological cardioversion shows some important advantages: immediate effect, high success rate, and safety in hemodynamically unstable patients. There are three main groups of patients in whom sinus rhythm is a benefit:(i)patients with severe symptoms during the arrhythmia,(ii)patients with recent-onset atrial fibrillation in order to prevent electrical remodeling,(iii)patients with structural heart disease, such as hypertension and ventricular hypertrophy, which can achieve a significant hemodynamic improvement by restoring sinus rhythm. There are several techniques to perform an electrical cardioversion, each with specific indications, advantages, and limitations. The method most often used to restore sinus rhythm is the external direct current cardioversion; however, this technique has some disadvantages, since it requires a high energy and usually general anesthesia. 2. Esophageal Electrical Cardioversion This type of cardioversion may overcome some limitations of the standard external cardioversion. In some patients, the high thoracic impedance, due to emphysema or to a high body surface, changes the transmission of direct current shock through the

References

[1]  S. Levy, “Epidemiology and natural history of atrial fibrillation,” in Non Pharmacological Treatment of Atrial Fibrillation, M. Santini, Ed., pp. 9–24, Arianna editrice, Casalecchio, Italy, 2002.
[2]  A. Elhendy, F. Gentile, B. K. Khandheria et al., “Predictors of unsuccessful electrical cardioversion in atrial fibrillation,” American Journal of Cardiology, vol. 89, no. 1, pp. 83–86, 2002.
[3]  R. E. Kerber, “Transthoracic cardioversion of atrial fibrillation and flutter: standard techniques and new advances,” The American journal of cardiology, vol. 78, no. 8A, pp. 22–26, 1996.
[4]  H. G. Li, D. L. Jones, R. Yee, and G. J. Klein, “Defibrillation shocks increase myocardial pacing threshold: an intracellular microelectrode study,” American Journal of Physiology, vol. 260, no. 6, pp. H1973–H1979, 1991.
[5]  Y. Cai, S. Fan, D. Feng et al., “Transesophageal low-energy cardioversion in an animal model of life-threatening tachyarrhythmias,” Circulation, vol. 80, no. 5, pp. 1354–1359, 1989.
[6]  M. Santini, C. Pandozi, F. Colivicchi et al., “Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration,” European Heart Journal, vol. 21, no. 10, pp. 848–855, 2000.
[7]  P. P. McKeown, S. Croal, J. D. Allen, J. Anderson, and A. A. J. Adgey, “Transesophageal cardioversion,” American Heart Journal, vol. 125, no. 2, pp. 396–404, 1993.
[8]  L. Santini, B. Magris, A. Topa et al., “Outpatient oesophageal-precordial electrical cardioversion of atrial fibrillation: an effective and safe technique to restore sinus rhythm,” Journal of Cardiovascular Medicine, vol. 8, no. 7, pp. 488–493, 2007.
[9]  L. Santini, M. M. Gallagher, L. P. Papavasileiou et al., “Transthoracic versus transesophageal cardioversion of atrial fibrillation under light sedation: a prospective randomized trial,” Pacing and Clinical Electrophysiology, vol. 30, no. 12, pp. 1469–1475, 2007.
[10]  M. F. Scholten, A. S. Thornton, L. J. Jordaens, J. R. Roelandt, R. E. Kerber, and I. Kronzon, “Usefulness of transesophageal echocardiography using a combined probe when converting atrial fibrillation to sinus rhythm,” American Journal of Cardiology, vol. 94, no. 4, pp. 470–473, 2004.
[11]  I. Kronzon, P. A. Tunick, M. F. Scholten, R. E. Kerber, and J. R. T. C. Roelandt, “Combined transesophageal echocardiography and transesophageal cardioversion probe: technical aspects,” Journal of the American Society of Echocardiography, vol. 18, no. 3, pp. 213–215, 2005.
[12]  S. Mittal, S. Ayati, K. M. Stein et al., “Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks,” Circulation, vol. 101, no. 11, pp. 1282–1287, 2000.
[13]  R. L. Page, R. E. Kerber, J. K. Russell et al., “Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial,” Journal of the American College of Cardiology, vol. 39, no. 12, pp. 1956–1963, 2002.
[14]  C. H. Tegeler and T. R. Downes, “Cardiac imaging in stroke,” Stroke, vol. 22, no. 9, pp. 1206–1211, 1991.
[15]  A. L. Klein, R. A. Grimm, I. W. Black et al., “Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study: a randomized, controlled trial,” Annals of Internal Medicine, vol. 126, no. 3, pp. 200–209, 1997.
[16]  D. W. Benson, A. Dunnigan, and D. G. Benditt, “Follow-up evaluation of infant paroxysmal atrial tachycardia: transesophageal study,” Circulation, vol. 75, no. 3, pp. 542–549, 1987.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133